Women With MS Less Likely to Receive Treatment Than Men


Is “therapeutic inertia” to blame?

by
Judy George, Deputy Managing Editor, MedPage Today

September 21, 2024

Women were less likely than men to be treated for relapsing multiple sclerosis (MS), French registry data showed.

Women had a lower probability of receiving any disease-modifying treatment (DMT) and were even less likely to get high-efficacy DMTs, reported Antoine Gavoille, MD, of Hospices Civils de Lyon in France, at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) annual meeting in Copenhagen.

The study included 22,657 relapsing MS patients with disease onset at an average age of 30. Most (74.2%) were women.

Over a median follow-up of 11.6 years, women were significantly less likely to be treated with any DMT (OR 0.92, 95% CI 0.87-0.97) or with a high-efficacy DMT (OR 0.80, 95% CI 0.74-0.86), Gavoille said.

The findings suggest “therapeutic inertia” in women, noted co-author Sandra Vukusic, MD, PhD, also of Hospices Civils de Lyon.

“The main impact of this inertia is the less effective control of disease activity during DMT-free periods, leading to the accumulation of lesions and an increased risk of long-term disability,” she said. “This represents a real loss of opportunity for women, especially in an era where DMTs are so effective when used early.”

Treatment decisions can be influenced by a desire to become pregnant well before pregnancy occurs — even if it doesn’t occur, Gavoille noted. Because of this, women in childbearing years might be under-exposed to DMTs or to high-efficacy DMTs compared with men.

“Neurologists might be hesitant to prescribe DMTs, particularly if they are not comfortable with managing pregnancy-related issues,” Vukusic pointed out.

Women don’t want to take risks that may harm their child or pregnancy and may have concerns about congenital malformations, fetal loss, or fetal growth disorders, she added. “Women will also experience discomfort if their neurologist seems uncertain,” she said.

The researchers evaluated data from the French MS registry (OFSEP), including all MS patients with a relapsing onset from ages 18 through 40 who were followed from 1997 through 2022.

The primary outcome was the yearly probability of receiving any DMT — adjusted for disease severity (relapses, disability scores, and MS phenotype) and pregnancy/post-partum periods — to identify treatment differences in men and women not tied directly to pregnancy.

Differences in treatment varied among DMTs and years:

  • Teriflunomide (OR 0.87), S1PR-modulators (OR 0.78), and anti-CD20 drugs (OR.80) were significantly underused by women throughout the time they were available
  • Interferon beta (OR 0.99) and natalizumab (OR 0.96) were less used initially by women, then used equally between men and women after some time
  • Glatiramer acetate (OR 1.27) and fumarate (OR 1.17) were used equally at first, then more frequently in women

Overall, differences in use appeared after 5 years of disease duration for DMTs and after 3 years for high-efficacy DMTs, and didn’t vary significantly by patient age.

A subanalysis of 5,268 patients showed that women were undertreated outside of pregnancy and post-partum periods, with further declines starting about 9 months before conception. This indicates that pregnancy may account for some of the treatment gap between men and women, but doesn’t explain everything, Gavoille said.

The findings indicate a need to reassess how treatment decisions are made for younger women with MS, Vukusic noted. “Women may not be receiving the most effective therapies at the optimal time, often due to concerns about pregnancy risks that may never materialize,” she observed.

“The use of DMTs and high-efficacy DMTs is frequently limited by potential and unknown risks associated with pregnancy, as there is often insufficient data available when these drugs first come to market,” she added.

  • Judy George covers neurology and neuroscience news for MedPage Today, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more. Follow

Disclosures

Gavoille reported no disclosures.

Vukusic reported relationships with from Biogen, BMS-Celgene, Janssen, Merck, Novartis, Roche, Sandoz, and Sanofi-Genzyme.

Primary Source

European Committee for Treatment and Research in Multiple Sclerosis

Source Reference: Gavoille A, et al “Is there therapeutic inertia in women with MS?” ECTRIMS 2024, Abstract 1316/O089.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Tata Tigor CNG: 5 things we liked and 5 things we didn’t thumbnail

Tata Tigor CNG: 5 things we liked and 5 things we didn’t

CNG is not rocket science. It’s been around for ages, and exploiting this resource doesn’t require carmakers to spend billions of R&D money. A recent surge is being witnessed with manufacturers wanting to offer CNG versions of their latest entry-level cars. Tata Motors’ arsenal of greener, cleaner motoring now includes two new CNG versions of…
Read More
Leicester-Shire & Rutland School Games Officially Launched thumbnail

Leicester-Shire & Rutland School Games Officially Launched

This year’s School Games Ambassadors, World Junior Road Race Champion Lucy Garner, and England U21 and Leicester Hockey Club first team player Josie Inverdale, officially launched the Leicester-Shire & Rutland School Games last week. The inaugural Leicester-Shire & Rutland School Games Launch was held on February 27th at Leicester Grammar School; which will also host…
Read More
Ramalan Zodiak Hari Ini 4 Februari: Aries Saatnya Menyingkirkan Pikiran Negatif, Taurus Penting untuk Memiliki Keyakinan thumbnail

Ramalan Zodiak Hari Ini 4 Februari: Aries Saatnya Menyingkirkan Pikiran Negatif, Taurus Penting untuk Memiliki Keyakinan

BAGAIMANA peruntungan zodiakmu hari ini? Melansir horoscopefriends, berikut ramalan zodiak hari ini untuk Aries dan Taurus. ARIES Ini adalah hari untuk beraksi, kamu tahu apa yang kamu inginkan, dan percaya pada dirimu sendiri. Kamu mungkin terlibat dalam pertengkaran keluarga, tetapi cobalah untuk tidak membiarkan situasi menjadi tidak terkendali dan mengatakan hal-hal yang mungkin kamu sesali,…
Read More
Nurses in Crisis Over Covid Dig In for Better Work Conditions thumbnail

Nurses in Crisis Over Covid Dig In for Better Work Conditions

Nurses and health care workers across the country are finding strength in numbers and with labor actions not seen in years. In California, which has a strong union tradition, Kaiser Permanente management misjudged workplace tensions during the covid-19 crisis and risked a walkout of thousands when union nurses balked at signing a four-year contract that…
Read More
Index Of News
Total
0
Share